CollPlant Biotechnologies Cash Flow Statement (2017-2026) | CLGN

Cash Flow Statement Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
7.09M-0.290.24M-3.86M8.14M-0.404.40M3.71M-1.67M-4.38M-4.69M-4.20M-4.21M-4.33M-3.88M-1.65M-3.35M-3.48M19.77M-3.12M
Depreciation and Depletion (Quarter)
0.20M0.22M
Share-based Compensation (Quarter)
0.47M-0.37M2.92M0.46M0.59M0.68M0.44M0.51M0.34M0.52M0.56M0.29M0.49M0.52M0.42M0.35M0.28M-0.02M
Cash from Discontinued Operations (Quarter)
-3.26M-2.82M
Gains from Investment Securities (Quarter)
Non-cash Items (Quarter)
-2.34M-2.52M
Cash from Operations (Quarter)
-3.38M-2.82M-2.42M-3.21M-3.96M-3.19M-13.70M-3.45M-3.74M6.78M-2.35M-3.25M-3.93M-3.45M-3.46M-2.44M-2.88M-2.94M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)
0.09M0.10M0.11M0.11M0.11M0.12M0.46M0.12M0.14M0.13M0.17M
Depreciation & Amortization (CF) (Quarter)
0.18M0.20M0.22M0.24M0.26M0.28M0.29M0.28M0.27M0.27M0.28M0.28M0.26M0.26M0.24M0.23M0.22M0.22M
Change in Working Capital
Change in Receivables (Quarter)
-0.10M0.14M0.56M0.27M-0.01M0.26M-0.31M-9.84M10.16M0.00M-0.09M-0.16M0.24M-0.14M-0.01M0.01M
Change in Inventory (Quarter)
0.34M-0.21M0.18M-0.19M-0.09M0.23M-0.31M-0.34M0.19M0.05M0.86M0.07M0.21M-0.01M0.01M0.12M0.01M-0.03M
Change in Account Payables (Quarter)
-0.20M0.17M0.17M-0.03M-0.24M0.12M0.25M-0.25M-0.12M-0.02M0.24M0.14M0.02M-0.13M-0.14M-0.20M0.05M-0.01M
Change in Accured Expenses (Quarter)
-0.08M-0.63M-0.46M-0.33M0.03M-0.16M0.48M0.07M-0.09M-0.10M0.33M0.06M-0.39M-0.05M0.03M0.14M-0.11M0.02M
Other Working Capital Changes (Quarter)
-0.16M-0.17M-0.03M-0.03M0.12M0.14M0.16M0.17M0.18M0.16M0.17M0.17M
Investing Activities
Capital Expenditures (Quarter)
-0.24M-0.60M-1.43M-0.30M-0.38M-0.31M-1.27M-0.14M-0.34M-0.24M-0.23M-0.08M-0.20M-0.14M-0.06M-0.00M-0.00M-0.01M
Change in Intangibles (Quarter)
-0.03M-0.03M-0.16M-0.01M-0.01M-0.01M-0.04M
Acquisitions (Quarter)
-2.24M8.27M
Change in Acquisitions & Divestments (Quarter)
-30.00M-20.00M-0.21M
Cash from Investing Activities (Quarter)
-0.27M9.37M-31.56M29.89M-0.34M-0.32M-0.30M-0.14M-0.40M-0.24M-0.37M-0.08M-0.26M-0.14M-0.06M-0.00M-0.00M-0.01M
Financing Activities
Other financing activities (Quarter)
1.36M1.75M0.14M1.47M0.40M0.80M0.09M0.22M0.01M
Cash from Financing Activities (Quarter)
1.36M1.75M0.14M1.47M0.40M0.80M0.09M0.22M0.01M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
Additional items
Exchange Rate Effect (Quarter)
-0.97M-0.97M0.14M-0.97M-0.97M-0.97M-0.61M-0.97M-0.97M-0.97M0.20M-0.12M-0.12M0.04M0.06M0.04M-0.01M-0.01M
Change in Cash (Quarter)
-2.30M11.82M-16.12M28.15M-5.02M-2.78M17.10M-3.07M-4.21M6.62M-2.52M-3.45M-4.30M-3.55M-3.46M0.70M-2.89M-2.96M
Beginning Cash Balance (Quarter)
13.37M13.37M
Free Cash Flow (Quarter)
-3.14M-2.21M-0.99M-2.92M-3.57M-2.88M-12.42M-3.31M-3.41M7.02M-2.12M-3.17M-3.73M-3.31M-3.40M-2.44M-2.88M-2.92M
Net Cash Flow (Quarter)
-2.29M8.29M-33.83M28.15M-4.29M-3.51M-13.60M-2.79M-4.05M6.75M-2.72M-3.33M-4.19M-3.59M-3.52M-2.44M-2.88M-2.95M